KALA BIO, Inc.
KALA
Rank in Stocks
#30879
Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the... Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseases. The company was established in 2009 by co-founders Justin Hanes, Robert S. Langer, and Colin R. Gardner, and its headquarters are located in Arlington, Massachusetts.
Share Price
$0.75
Last synced: 2026-07-31
Market Cap
$14.50M
Change (1 day)
2.78%
Change (1 year)
-98.84%
Country
US
Trade KALA BIO, Inc. (KALA)
Category
Healthcare
Market Capitalization of KALA BIO, Inc.(KALA)
Market Cap: $14.50M
As of October 2026 KALA BIO, Inc. has a market cap of $14.50M. This makes KALA BIO, Inc. the world's 30879th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of KALA BIO, Inc. from 2018 to 2026
KALA compared with Top 5 Most Popular stocks
| Price of KALA | Asset B | Mkt. of B | Results | |
|---|---|---|---|---|
$36,797,562
$27.17K
|
$5.167T | +19,016,827,582.78% | ||
|
$35,713,222
$27.17K
|
$5.015T | +18,456,445,208.38% | ||
|
$29,258,373
$27.17K
|
$4.108T | +15,120,606,128.15% | ||
|
$27,787,775
$27.17K
|
$3.902T | +14,360,607,019.39% | ||
|
$19,153,214
$27.17K
|
$2.689T | +9,898,301,850.66% |
